ConductScience.org, home

Paper24924752

Eculizumab treatment for rescue of renal function in IgA nephropathy.

Rosenblad T and 5 others. Pediatr Nephrol, 2014. Cited by 96 papers, by iCite.

Cite this record

ConductScience Library. Eculizumab treatment for rescue of renal function in IgA nephropathy. Papers, record 24924752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24924752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Eculizumab treatment for rescue of renal function in IgA nephropathy.
PubMed
Journal
Pediatr Nephrol
PubMed
Year
2014
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
3.49
iCite
Revised in PubMed
2022-03-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosenblad TTherese
2Rebetz JJohan
3Johansson MMartin
4Békássy ZZivile
5Sartz LLisa
6Karpman DDiana

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Monoclonal, HumanizedMajor topic
Complement Inactivating AgentsMajor topic
Glomerulonephritis, IGAMajor topic
KidneyMajor topic
Salvage TherapyMajor topic
Adolescent
Biopsy
Creatinine
Glomerular Filtration Rate
Humans
Kidney Glomerulus
Male
Renal Insufficiency

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120734203IgA nephropathy associated with a novel N-terminal mutation in factor H.Eur J Pediatr2011https://conductscience.org/library/papers/20734203PubMed
219162324Is complement factor H a susceptibility factor for IgA nephropathy?Mol Immunol2009https://conductscience.org/library/papers/19162324PubMed
322111871Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.BMC Nephrol2011https://conductscience.org/library/papers/22111871PubMed
416687629Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.J Am Soc Nephrol2006https://conductscience.org/library/papers/16687629PubMed
522792353Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.PLoS One2012https://conductscience.org/library/papers/22792353PubMed
621399633Genome-wide association study identifies susceptibility loci for IgA nephropathy.Nat Genet2011https://conductscience.org/library/papers/21399633PubMed
73573542Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis.Kidney Int1987https://conductscience.org/library/papers/3573542PubMed
89264010Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.Kidney Int1997https://conductscience.org/library/papers/9264010PubMed
919571791The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.Kidney Int2009https://conductscience.org/library/papers/19571791PubMed
1023072577Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.Annu Rev Med2013https://conductscience.org/library/papers/23072577PubMed
116205804Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy.Clin Nephrol1984https://conductscience.org/library/papers/6205804PubMed
1219230171C5b-9 glomerular deposition and tubular alpha3beta1-integrin expression are implicated in the development of chronic lesions and predict renal function outcome in immunoglobulin A nephropathy.Scand J Urol Nephrol2008https://conductscience.org/library/papers/19230171PubMed
1311231363Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.Kidney Int2001https://conductscience.org/library/papers/11231363PubMed
143586493Complement activation in IgA nephropathy.Kidney Int1987https://conductscience.org/library/papers/3586493PubMed
1511791795Inherited factor H dysfunction and complement-associated glomerulonephritis in renal grafts of first and second transplantations.Clin Transplant2001https://conductscience.org/library/papers/11791795PubMed

Download CSV of references

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
42488643Case report: Sequential complement inhibition and BAFF/APRIL blockade in progressive IgA nephropathy and IgA vasculitis nephritis: a report of two cases.Front Immunol2026https://conductscience.org/library/papers/42488643PubMed
41788457Immunoglobulin A Nephropathy With Associated Thrombotic Microangiopathy: Biopsy and Clinical Case Series.Clin Med Insights Case Rep2026https://conductscience.org/library/papers/41788457PubMed
41714421Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy.Pediatr Nephrol2026https://conductscience.org/library/papers/41714421PubMed
41266601IgA nephropathy new therapies: from data in adults to application in children.Pediatr Nephrol2026https://conductscience.org/library/papers/41266601PubMed
41111558The Complement System: An Important New Therapeutic Target in IgA Nephropathy.Glomerular Dis2025https://conductscience.org/library/papers/41111558PubMed
40808688Opportunities and challenges in the treatment of IgA nephropathy.Front Pharmacol2025https://conductscience.org/library/papers/40808688PubMed
39968279The road ahead: emerging therapies for primary IgA nephropathy.Front Nephrol2025https://conductscience.org/library/papers/39968279PubMed
39188719Contemporary review of IgA nephropathy.Front Immunol2024https://conductscience.org/library/papers/39188719PubMed
38777962Drugs in Development to Treat IgA Nephropathy.Drugs2024https://conductscience.org/library/papers/38777962PubMed
38344730Systematic Review of the Link Between Oxford MEST-C Classification and Complement Activation in IgA Nephropathy.Kidney Int Rep2024https://conductscience.org/library/papers/38344730PubMed
38053977Targeting complement in IgA nephropathy.Clin Kidney J2023https://conductscience.org/library/papers/38053977PubMed
37889398Clinical advances in immunotherapy for immune-mediated glomerular diseases.Clin Exp Med2023https://conductscience.org/library/papers/37889398PubMed
37747686Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.Drugs2023https://conductscience.org/library/papers/37747686PubMed
37705895Challenges in IgA Nephropathy Management: An Era of Complement Inhibition.Kidney Int Rep2023https://conductscience.org/library/papers/37705895PubMed
37576817A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022.Front Pharmacol2023https://conductscience.org/library/papers/37576817PubMed
37398689Immune abnormalities in IgA nephropathy.Clin Kidney J2023https://conductscience.org/library/papers/37398689PubMed
37240105Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease.Int J Mol Sci2023https://conductscience.org/library/papers/37240105PubMed
37216524Germline C1GALT1C1 mutation causes a multisystem chaperonopathy.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37216524PubMed
36241249[Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study].Beijing Da Xue Xue Bao Yi Xue Ban2022https://conductscience.org/library/papers/36241249PubMed
35757129Hypocomplementemic Atypical IgA Vasculitis: A Case Report.Front Pediatr2022https://conductscience.org/library/papers/35757129PubMed

See all 60 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IGHA13493PubTator's text mininghttps://conductscience.org/library/genes/3493

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24924752

GET https://conductscience.org/api/papers/v1/24924752/cited_by?page=2